Biostatistician |
| Job Description Responsible for providing statistical support to clinical studies or projects as ... |
|
Marketing Manager for Biochemicals |
| EMD Biosciences, Inc., a worldwide supplier of life science reagents to the biotech research ... |
|
Research Associate (Cell / Molecular Biology) |
| BioPhase Solutions specializes in recruiting top talented professionals for San Diego's Scientific ... |
|
Cell Culture Biologist (Bioreactor) |
| BioPhase Solutions specializes in recruiting top talented professionals for San Diego's Scientific ... |
|
Research Associate - FACS |
| OVERALL SUMMARY OF POSITION:
This position will focus on cell culture development for new and ... |
|
Pharmaceutical Sales Rep (Oncology) - Southern California |
| PharmaCare Specialty Pharmacy, a wholly owned subsidiary of CVS Pharmacy, is seeking a Regional B... |
|
Lead - Staff Manufacturing Associate |
| Innovation is in our genes.
Illumina (NASDAQ: ILMN) develops next-generation tools for large-scale ... |
|
Scientific Technician |
| Beckman Coulter makes products that are used in hospital laboratories, physicians' offices and
... |
|
Senior EHS Technician (AMLN-02235) |
| Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other ... |
|
Sr. Buyer / Purchasing Associate |
| BioPhase Solutions specializes in recruiting top talented professionals for San Diego's Scientific ... |
|
|
Health Outcomes Scientist (AMLN-02293)
| Details |
Country: USA
Location: CA San Diego
Total applied: 24
Job Type: Employee
Job Status: Full Time
|
|
Health Outcomes Scientist (AMLN-02293)
Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development, and commercialization of innovative, cost-effective medicines. Our rapid growth has created the following outstanding opportunity in San Diego, CA:
Health Outcomes Scientist
(AMLN-02293)
Essential Duties and Responsibilities: Conduct health outcomes research including designing research protocols, preparing statistical analysis plans, executing and managing protocols, analyzing and interpreting results using expertise in econometrics and biostatistics, preparing technical reports and manuscripts for internal, external and peer review communication. Collaborate productively with fellow researchers on, retrospective and prospective research including a variety of databases such as, medical, laboratory and pharmacy claims, medical records, patient reported outcomes and predictive modeling. Plan, organize and schedule multiple activities to meet research objectives.Communicate effectively with business partners, internal cross functional teams and external customers. Author abstracts, posters and manuscripts for peer reviewed meetings and journals to be presented at national conferences. Interface with key opinion leaders and business partners to build and enhance long-term research relationships.
Qualifications: Minimum of Master?s level research training in the field of health services research, health economics, pharmacoeconomics, or related field. Clinical degree (Pharm.D, RPh, RN, MD, PA) with relevant research experience also considered.PhD preferred.
Education/Experience:Minimum 3 years of pharmaceutical industry or related experience. Minimum of 5 years experience in health economics and/or outcomes research experience. Demonstrated peer-reviewed publication history. Ability to work within and lead cross-functional teams
Amylin offers competitive compensation, benefits and stock options. Amylin maintains a drug and alcohol free workplace and all offers of employment are contingent upon satisfactory completion of a pre-employment drug and alcohol test. Please apply online at: http://careers.amylin.com AA/EEO Employer.
Amylin
Pharmaceuticals
|
| Related jobs |
|
|
Associate Director, New Product Planning (AMLN-02296)
Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development, and commercialization ...
|
|
|
Research Assistant II - Assay Development
BD Diagnostics - GeneOhm, a business unit of BD, is a leader in the development and manufacture of molecular diagnostic test kits. We are seeking a Research A...
|
|
|
Quality Assurance
Lab Pros is seeking candidates for a Quality Assurance Specialist opening with a leading Biotech firm in the area.
Quality Assurance Associate
?Assist with ...
|
|
|
Product Manager - Genotyping
Innovation is in our genes.
Illumina (NASDAQ: ILMN) develops next-generation tools for large-scale analysis of genetic variation and function. The results will pave ...
|
|
|
Histology/Necropsy Lead (Principal Scientist R5/R6)
Description: The successful candidate will be responsible for all aspects of leadership and management of the necropsy and histology function within La Jolla Safety S...
|
|
|
Application Scientist
Application Scientist
Location: San Diego, CA
Job Code: STTAM
SciTegic, a wholly owned subsidiary of Accelrys, Inc., designs, develops, and markets data ...
|
|
|
:::Marketing Manager - Surgical Devices/Implants - START UP!!!:::
What happens when you mix one part fast-growing company, one part high-growth job opportunity, and one part your excellent experience in medical device marketing?
The ...
|
|
|
Clinical Data Specialist
Why Wait? Our passion is unmistakable! Have you ever wished you could be as excited about your career as you once were? Or wanted to take your career to the next level ...
|
|
|
Patent Attorney or Agent - Excellent Growth Opportunity
About Hollis-Eden Pharmaceuticals:
HollisEden Pharmaceuticals innovative science has attracted the industry's most creative and successful employees. Our culture ...
|
|
|
Assoc Dir/Director, CMC Team Leader (AMLN-02271)
Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development, and commercialization ...
|
|
| Related press releases |
Revenue tries to deflect 50% tax fears
More than a million people could be saved from filling in tax returns under new proposals from the Inland Revenue. Officials said yesterday the move was part of a plan to...
|
|
Basic instinct
New from Rover, the CityRover appears to have been named after a cut-price bus ticket, and it operates on pretty much the same principles. For one slim down-payment, it o...
|
|
It pays to shop for home cover
New research reveals the benefits of shopping around for home insurance, with the average difference in premiums between the cheapest and most expensive providers a stagg...
|
|
Spectre of council tax revolt looms
The prospect of widespread civil disobedience against inflation-busting council tax increases grew yesterday when an 83-year-old woman vowed to go to jail rather than com...
|
|
Online spending 'almost doubled' in 2003
Britons are spending almost twice as much money on internet transactions than they were a year ago, payment brand Visa announced today.
According to Visa's figures, UK s...
|
|
On the Trail of an Intelligent commission
Isa and Pep investors can recover the tax break they lose from April by getting IFAs and fund managers to boost their annual cash take by joining a new - and controversia...
|
|
It's safety in numbers as anti-fraud cards arrive
The anti-fraud 'chip and pin' credit and debit cards are beginning to arrive on people's door-mats - but there could still be a wait before customers get to use them.
A...
|
|
Jackson in crisis over $70m bank loan
Undaunted by declining CD sales, the possibility of a prison sentence and the reported collapse of his personal fortune, Michael Jackson is still spending around $2m (mor...
|
|
MPs criticise credit card industry
The Treasury select committee has accused the credit card industry of showing a "lack of commitment" to improving clarity and fairness for consumers in a letter to the ma...
|
|
How to go from riches to rags in just two years - the Leeds United way
How bad is the situation?
Oh, it's bad. On October 28 last year, Leeds announced the biggest ever pre-taxes losses by an English football club - ?49.5m for 2002-2003, le...
|
|
|
|